Samuel E. Perkins
Texas A&M University
7 Papers
58 Citations
Samuel E. Perkins is an academic researcher from Texas A&M University. The author has contributed to research in topics: Fibrinogen binding & Clumping factor A. The author has an hindex of 5, co-authored 7 publications. Previous affiliations of Samuel E. Perkins include Texas Medical Center.
Chat about Author
Papers
Clumping factor B (ClfB), a new surface‐located fibrinogen‐binding adhesin of Staphylococcus aureus
D. Ni Eidhin,Samuel E. Perkins,Patrice Francois,Pierre Vaudaux,Magnus Höök,Timothy J. Foster +5 more
TL;DR: The surface‐located fibrinogen‐binding protein (clumping factor; ClfA) of Staphylococcus aureus has an unusual dipeptide repeat linking the ligand binding domain to the wall‐anchored region, suggesting that it could contribute to the pathogenicity of biomaterial‐related infections.
474
Patent
Extracellular matrix-binding proteins from staphylococcus aureus
Joseph M. Patti,Timothy J. Foster,Elizabet Josefsson,Deirdre Ni Eidhin,Magnus Höök,Samuel E. Perkins +5 more
- 25 Nov 1998
TL;DR: Isolated extracellular matrix-binding proteins, designated ClfB, SdrB and SdrC, are useful for the prevention, inhibition, treatment and diagnosis of S aureus infection and as scientific research tools as mentioned in this paper.
41
Crystallization of ClfA and ClfB fragments: The fibrinogen-binding surface proteins of Staphylococcus aureus
Champion Deivanayagam,Samuel E. Perkins,Sita Danthuluri,Rick T. Owens,Todd Bice,Tamanna Nanavathy,Timothy J. Foster,Magnus Höök,Sthanam V.L. Narayana +8 more
TL;DR: Recombinant constructs encoding the fibrinogen-binding domains of ClfA and ClfB from Staphylococcus aureus have been crystallized, suggesting one molecule per asymmetric unit.
17
Patent
Extracellular matrix-binding protein derived from staphylococcus aureus
Deirdre Ni Eidhin,Timothy J. Foster,Magnus Hook,Elizabet Josefsson,Joseph M. Patti,Samuel E. Perkins,ニー， エイデイン，デイールドル,ジヨセフソン，エリザベツト,パーキンス，サヌエル，イー,エム． パテイ，ジヨセフ,フオスター，テイモテイ，ジエイ．,フツク，マグナス，エイ． +11 more
- 05 Feb 2010
TL;DR: An isolated extracellular matrix binding protein of S. aureus and an active fragment thereof, and a method for preventing, diagnosing, treating, or monitoring the progress of a bacterial infection caused by S. anaphora as mentioned in this paper.
1